The Furuya Laboratory focuses on two main areas: 1) the role of sphingolipid signaling cascade in cancers, such as colorectal, breast and bladder cancer, 2) urinary biomarkers for early detection, prognostics and prediction of the response to treatment of bladder cancer. The Furuya Laboratory has extensive research experience in animal cancer models including colorectal, bladder, breast and tongue cancers.
Hideki Furuya, PhD, is a translational molecular biologist with a strong background in animal cancer models. He earned PhD from Meiji University, where he studied animal carcinogenesis. During his postdoctoral trainings at the Medical University of South Carolina and the University of Hawaii, he was trained in molecular biology. As junior faculty at the University of Hawaii Cancer Center, he was trained cancer biology. In 2019, he established his laboratory at Cedars-Sinai.
Hideki Furuya, PhD
Breakthrough Research Areas
- The role of sphingosine kinase 1 expression in abdominal immune cells in colorectal cancer.
- Urinary biomarkers for bladder cancer detection, diagnosis and prognosis as well as prediction of treatment response.
- Development of gene targeted therapy for cancers.
- Chung Lab: part of the genitourinary cancer research group
- Bhowmick Lab: part of the genitourinary cancer research group
- Theodorescu Lab: part of the bladder cancer research group
- Keith Chan Lab: part of the bladder cancer research group
- Rosser Lab: part of the bladder cancer research group
- Knott Lab: tumor microenvironment research project
Monoclonal Antibody against CXCL1 (HL2401) as a Novel Agent in Suppressing IL6 Expression and Tumoral Growth.
Miyake M, Furuya H, Onishi S, Hokutan K, Anai S, Chan O, Shi S, Fujimoto K, Goodison S, Cai W, Rosser CJ.
Effectiveness of two different dose administration regimens of an IL-15 superagonist complex (ALT-803) in an orthotopic bladder cancer mouse model.
Furuya H, Chan OTM, Pagano I, Zhu C, Kim N, Peres R, Hokutan K, Alter S, Rhode P, Rosser CJ.
J Transl Med. 2019 Jan 17;17(1):29.
Diagnostic biomarkers in non-muscle invasive bladder cancer.
Faiena I, Rosser CJ, Chamie K, Furuya H.
World J Urol. 2019 Oct;37(10):2009-2016.
Contact the Furuya Lab
110 N. George Burns Rd.
Davis, Room 2025
Los Angeles, CA 90048